Full Press Release Details
IDEAYA Biosciences Announces Plans for Investor R D Day and Participation in Jefferies London Healthcare Conference.
IDYA
IDEAYA Biosciences Announces Plans for Investor R D Day and Participation in Jefferies London Healthcare Conference
Key Takeaway: IDEAYA Biosciences Announces Plans for Investor R D Day and Participation in Jefferies London Healthcare Conference
Price reaction · baseline $27.17 (2023-10-31 close) · hit after-hours · clean, no other IDYA news in the window
day 0 close
+6.3%
day 1 · peak
+9.2%
day 3
+6.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma